Sarcopenia: the quiet strength loss — and why it is not fate
The 30-second answer
Sarcopenia has been officially recognised as its own muscle disease since the consensus of the European Working Group on Sarcopenia in Older People (EWGSOP2, 2019) — it is diagnosed primarily via strength (grip strength, chair-stand test), not via muscle mass. The reason: from roughly midlife, muscle mass declines only slowly (about 0.4 to 0.5 percent a year, faster from 75), while strength falls two to five times as fast — around 3 to 4 percent a year in men. Strength loss is the honest story, not the muscle shrinkage on a scale. The good news: a meta-analysis of 13 randomised trials (546 participants, all with a diagnosed sarcopenia) shows that resistance training still measurably improves grip strength, gait speed and the ability to stand up even once the diagnosis is already made. Protein or amino acids added to training help function but do not replace training — and, as the consensus explicitly states, diagnosis itself belongs in medical or geriatric hands.
What's proven — and what isn't
| Area | Evidence | Statement |
|---|---|---|
| Strength training once sarcopenia is diagnosed | A | A 2026 meta-analysis (13 randomised trials, 546 participants with a confirmed sarcopenia diagnosis) shows resistance training clearly improves grip strength (+2.95 kg), gait speed (+0.15 m/s) and the time for five repeated sit-to-stands (−1.79 seconds). This is not a prevention effect but a treatment effect — training works even once the diagnosis already stands. |
| Everyday self-tests as an early warning system | B | How fast you stand up from a chair, how firm your grip is and how briskly you walk are exactly the measures the field itself uses to spot sarcopenia. Honestly framed: a self-test at home is a reason to bring it up with a doctor — not a substitute for the medical diagnosis, which combines strength, mass and gait-speed measurements. |
| "Protein alone saves the muscle" | — | A 2026 meta-analysis of protein or amino acids added to resistance training finds improvements in function but no proven additional gain in muscle mass itself — and the evidence quality behind it is low. Nutrition supports the training stimulus; it does not replace it. |
| "It is too late for me" | — | The trials behind this dossier were run explicitly in people who already had a sarcopenia diagnosis — not in healthy people for prevention. The training effect showed up precisely in the group for whom "too late" is often the first reaction. |
| Muscle mass alone as a warning sign | C | A body-composition scale that reports only mass misses the crucial part of the story: under the international consensus, strength is the primary diagnostic criterion, and mass only confirms it. Looking only at kilograms of muscle mass means looking at the slower, less informative number. |
Evidence grades: A = strongly supported · B = supported in the right context · C = emerging/mixed evidence · D = experimental · — = no proven benefit. Quoted statements with a regulation number are officially reviewed health claims authorised by the EU — we use only those.
What sarcopenia actually is
Until a few years ago, sarcopenia was often used loosely to mean "muscle wasting in old age" — a vague gut feeling rather than a diagnosis. That has changed: the international expert consensus of the European Working Group on Sarcopenia in Older People (EWGSOP2, 2019) explicitly recognises sarcopenia as its own muscle disease — with a clear, if surprising, order of testing. At the centre is not muscle mass but strength: measured via grip strength (a hand dynamometer) or the chair-stand test (how fast someone can stand up from a chair five times in a row without using their arms). If this test comes back abnormal, muscle mass is measured to confirm it. If gait speed is also markedly slowed, the sarcopenia counts as severe.
This order — strength first, mass to confirm — is more than a technical detail: it explains why sarcopenia cannot be spotted by looking in the mirror or at a body-fat scale, and why diagnosis belongs in medical or geriatric hands. A suspicion can be formed at home — the diagnosis cannot.
The numbers, honestly: strength fades faster than mass
The uncomfortable but important number from longitudinal research (a 2012 review): from midlife onward, muscle mass declines comparatively slowly — by roughly 0.4 to 0.5 percent a year, accelerating from around age 75. Muscle strength, by contrast, falls two to five times as fast: declines of 3 to 4 percent a year have been measured in men. Sarcopenia is, first and foremost, a strength story, not a mass story — which is exactly why modern diagnostics start where the loss shows up first and most clearly.
In practical terms: anyone looking only at weight or bicep circumference sees half the truth. The decisive question is not "how much muscle mass do I still have?" but "how much strength can I still call on?"
What training gives back
Perhaps the most important message of this dossier: resistance training still works even once a sarcopenia diagnosis has already been made. A 2026 meta-analysis pooled 13 randomised trials with a total of 546 participants, all meeting EWGSOP2 criteria. The result under resistance training: grip strength up by 2.95 kg on average, gait speed up by 0.15 metres per second, and the time for five repeated sit-to-stands shortened by 1.79 seconds. These are not cosmetic improvements — they are exactly the measures that decide independent living, climbing stairs and standing up safely from the sofa.
What a practical starting point looks like — frequency, exercise choice, progression — is covered in strength training past 40. With an existing sarcopenia diagnosis, one thing is added: starting is a decision made together with a doctor and, where available, physiotherapy — not because training is dangerous, but because dose and exercise selection need to be fitted individually to existing limitations.
Self-observation — and when it belongs in a doctor's office
Without any equipment, three warning signs can be observed that also play a role in clinical diagnostics: the chair-stand test (standing up from a stable chair five times without using your arms — if that gets noticeably harder or takes noticeably longer than it used to, that is a signal), grip strength (increasing difficulty opening jars or carrying heavy bags), and gait speed (a familiar stretch taking longer than it did a year ago). A fourth, independent warning sign comes on top: unintentional weight loss.
Important framing: these observations are a reason to bring it up with a doctor, not a substitute for diagnosis — which combines strength, mass and gait-speed measurement under standardised criteria and belongs in medical or geriatric hands. In our app, this idea has a concrete home: the exercise chains deliberately start at steps like "seated leg extension" for anyone who cannot (yet) stand up unassisted — every step counts in full, and no starting point is too low to begin.
Sources
- 1. Cruz-Jentoft et al. — Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2, Age and Ageing 2019) — Accessed on: 2026-08-26
- 2. Mitchell et al. — Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength: a quantitative review (Frontiers in Physiology 2012) — Accessed on: 2026-08-26
- 3. Li et al. — The intervention effects of resistance exercise on sarcopenia in older adults: systematic review and meta-analysis (13 RCTs, n=546; BMC Geriatrics 2026) — Accessed on: 2026-08-26
- 4. Xie et al. — Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: systematic review and meta-analysis (BMC Musculoskeletal Disorders 2026) — Accessed on: 2026-08-26
This dossier is independent information and no substitute for medical diagnosis or treatment. For symptoms or questions about your thyroid, medication or supplements, talk to your doctor or pharmacist. This article deliberately contains no product advertising and no purchase links.